Surgery Partners, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $3.3B | $3.1B | $2.7B | $2.5B | $2.2B |
| Operating income | $389.5M | $348.8M | $328.0M | $345.2M | $302.2M |
| Operating expenses | $2.9B | $2.8B | $2.4B | $2.2B | $1.9B |
| Cash from operations | $274.3M | $300.1M | $293.8M | $158.8M | $87.1M |
| Capital expenditure | $78.7M | $90.4M | $88.8M | $80.6M | $57.6M |
| Free cash flow | $195.6M | $209.7M | $205.0M | $78.2M | $29.5M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $8.1B | $7.9B | $6.9B | $6.7B | $6.1B |
Shares outstanding 130.8M · Free float 91.8%
Annual filing data through FY ended December 31, 2025; float as of July 2, 2026.